Neovasc
Inc. is a specialty medical device company. It develops, manufactures
and markets products for the cardiovascular marketplace. The Company's
products include the Tiara (TM) mitral valve prosthesis in development
for the transcatheter treatment of mitral valve disease, the Neovasc
Reducer (TM) for the treatment of refractory angina and a line of
advanced biological tissue products that are used as key components in
third-party medical products, including transcatheter heart valves.
Please share this article
No comments:
Post a Comment